Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    biopure OR polyheme OR oxycyte OR hemolink OR stanate | Open Studies
Show Display Options
Rank Status Study
1 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
2 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
3 Unknown  A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Condition: Coronary Artery Disease
Intervention: Drug: HBOC-201 (hemoglobin glutamer-250 bovine)
4 Unknown  A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
Condition: Wounds and Injuries
Interventions: Drug: Hemoglobin-based oxygen carrier-201 (HBOC 201);   Other: Standard of Care

Indicates status has not been verified in more than two years